Royalty Pharma plc (RPRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Royalty Pharma plc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 21.65x | 13.24x | 11.08x | 404.10x | 26.67x | 19.92x |
| P/B Ratio | 2.58x | 1.64x | 1.93x | 3.08x | 2.86x | 4.03x |
| P/S Ratio | 7.02x | 5.03x | 5.34x | 7.74x | 7.22x | 9.15x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 65.6% | 57.1% | 63.4% | 13.7% | 62.5% | 75.2% |
| Net Margin | 32.4% | 37.9% | 48.2% | 1.9% | 27.1% | 45.9% |
| EBITDA Margin | 68.8% | 68.8% | 80.2% | 18.9% | 62.5% | 88.7% |
| Liquidity | ||||||
| Current Ratio | 0.97x | 1.44x | 7.90x | 2.19x | 16.81x | 8.76x |
| Quick Ratio | 0.97x | 1.44x | 7.90x | 2.19x | 16.81x | 8.76x |
| Leverage | ||||||
| Debt/Equity | 1.38x | 1.10x | 0.94x | 1.26x | 1.23x | 1.21x |
YoY = year-over-year change. Source: FMP..